Nunzia Pharmaceutical Company – OTC:NUNZ

Nunzia Pharmaceutical Company stock price today

$0.06
+0.05
+1900%
Financial Health
0
1
2
3
4
5
6
7
8
9

Nunzia Pharmaceutical Company key metrics

Market Cap
24.98M
Enterprise value
21.87M
P/E
-0.17
EV/Sales
N/A
EV/EBITDA
-0.22
Price/Sales
N/A
Price/Book
-113.53
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Nunzia Pharmaceutical Company stock price history

Nunzia Pharmaceutical Company stock forecast

Nunzia Pharmaceutical Company financial statements

Nunzia Pharmaceutical Company (OTC:NUNZ): Profit margin
Dec 2022 0 0
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
Nunzia Pharmaceutical Company (OTC:NUNZ): Debt to assets
Sep 2022 35373 226.69K 640.87%
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
Nunzia Pharmaceutical Company (OTC:NUNZ): Cash Flow
Dec 2022 0 0 0
Mar 2023 0 0 0
Jun 2023 0 0 0
Sep 2023 0 0 0

Nunzia Pharmaceutical Company other data

Nunzia Pharmaceutical Company (OTC:NUNZ): Insider trades (number of shares)
Period Buy Sel
Dec 2005 69396 0
Jan 2006 0 5386667
Apr 2006 110000 0
May 2006 58913 0
Jun 2006 10000 0
Oct 2006 125000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 25,000 $0.02 $500
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 100,000 $0.02 $1,900
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 10,000 $0.02 $180
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 3,913 $0.04 $157
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 55,000 $0.42 $23,265
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 110,000 $0.04 $4,620
Sale
HENRY G DAVID director, 10 percent owner
Common Stock 5,386,667 N/A N/A
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 34,698 $0.04 $1,319
Purchase
HENRY G DAVID director, 10 percent owner
Common Stock 34,698 $0.04 $1,319
Purchase
KRON ROGER ALAN director, officer: Chief Operat..
Common Stock 245,466 $0.06 $14,973
  • What's the price of Nunzia Pharmaceutical Company stock today?

    One share of Nunzia Pharmaceutical Company stock can currently be purchased for approximately $0.06.

  • When is Nunzia Pharmaceutical Company's next earnings date?

    Unfortunately, Nunzia Pharmaceutical Company's (NUNZ) next earnings date is currently unknown.

  • Does Nunzia Pharmaceutical Company pay dividends?

    No, Nunzia Pharmaceutical Company does not pay dividends.

  • How much money does Nunzia Pharmaceutical Company make?

    Nunzia Pharmaceutical Company has a market capitalization of 24.98M.

  • What is Nunzia Pharmaceutical Company's stock symbol?

    Nunzia Pharmaceutical Company is traded on the OTC under the ticker symbol "NUNZ".

  • What is Nunzia Pharmaceutical Company's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.

  • How do i buy shares of Nunzia Pharmaceutical Company?

    Shares of Nunzia Pharmaceutical Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Nunzia Pharmaceutical Company went public?

    Nunzia Pharmaceutical Company is publicly traded company for more then 16 years since IPO on 24 Jul 2009.

  • What is Nunzia Pharmaceutical Company's official website?

    The official website for Nunzia Pharmaceutical Company is nunziapharma.com.

  • Where are Nunzia Pharmaceutical Company's headquarters?

    Nunzia Pharmaceutical Company is headquartered at 1627 West 14th Street, Long Beach, CA.

  • How can i contact Nunzia Pharmaceutical Company?

    Nunzia Pharmaceutical Company's mailing address is 1627 West 14th Street, Long Beach, CA and company can be reached via phone at +7 146099117.

Nunzia Pharmaceutical Company company profile:

Nunzia Pharmaceutical Company

nunziapharma.com
Exchange:

OTC

Full time employees:

0

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

1627 West 14th Street
Long Beach, CA 90813

CIK: 0000886093
ISIN: US67097W1027
CUSIP: 67097W102